Maintenance Chemotherapy After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer
Status:
Terminated
Trial end date:
2017-03-16
Target enrollment:
Participant gender:
Summary
This study will assess the complete clinical response (no clinical evidence of remaining
disease or recurrence of disease)in rectal cancer that arises within 3 inches of the anal
opening after radiation therapy given at the same time as chemotherapy over a 6 week period,
followed by chemotherapy alone given three times over an additional 9 weeks. Follow-up begins
with an examination at the end of treatment (at 15 weeks), with ongoing follow-up every 4-6
weeks for one year.